Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,316 | 56 | 98.9% |
| Education | $15.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $317.34 | 15 | $0 (2021) |
| LEO Pharma Inc. | $239.82 | 10 | $0 (2024) |
| GENZYME CORPORATION | $199.70 | 11 | $0 (2024) |
| Galderma Laboratories, L.P. | $188.48 | 4 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $156.55 | 4 | $0 (2019) |
| Janssen Biotech, Inc. | $46.84 | 2 | $0 (2021) |
| Celgene Corporation | $34.86 | 2 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $32.31 | 1 | $0 (2017) |
| Allergan, Inc. | $28.70 | 2 | $0 (2022) |
| PFIZER INC. | $16.61 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.89 | 6 | GENZYME CORPORATION ($78.97) |
| 2023 | $61.97 | 3 | GENZYME CORPORATION ($61.97) |
| 2022 | $105.61 | 5 | LEO Pharma Inc. ($91.41) |
| 2021 | $476.69 | 17 | Galderma Laboratories, L.P. ($149.84) |
| 2020 | $51.03 | 3 | AbbVie Inc. ($38.88) |
| 2019 | $324.76 | 10 | Sun Pharmaceutical Industries Inc. ($156.55) |
| 2018 | $76.13 | 5 | AbbVie, Inc. ($18.90) |
| 2017 | $136.37 | 8 | Regeneron Healthcare Solutions, Inc. ($32.31) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Immunology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Immunology | ||||||
| 09/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Immunology | ||||||
| 06/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Immunology | ||||||
| 04/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: DERMATOLOGY | ||||||
| 04/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Immunology | ||||||
| 11/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Immunology | ||||||
| 08/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Immunology | ||||||
| 08/16/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Immunology | ||||||
| 08/16/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: DERMATOLOGY | ||||||
| 08/16/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: DERMATOLOGY | ||||||
| 04/20/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: DERMATOLOGY | ||||||
| 01/26/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: FACIAL AESTHETICS | ||||||
| 01/19/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: DERMATOLOGY | ||||||
| 11/03/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: DERMATOLOGY | ||||||
| 11/02/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: DERMATOLOGY | ||||||
| 10/20/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Immunology | ||||||
| 10/08/2021 | Galderma Laboratories, L.P. | ORACEA (Drug), AKLIEF | Food and Beverage | In-kind items and services | $149.84 | General |
| Category: ROSACEA | ||||||
| 10/06/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Immunology | ||||||
| 09/21/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: DERMATOLOGY | ||||||
| 07/15/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Immunology | ||||||
| 07/13/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: DERMATOLOGY | ||||||
| 06/16/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: DERMATOLOGY | ||||||
| 04/28/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: DERMATOLOGY | ||||||
| 03/24/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 5,895 | 11,623 | $2.1M | $473,279 |
| 2022 | 17 | 4,883 | 9,644 | $1.7M | $380,698 |
| 2021 | 27 | 4,553 | 8,627 | $1.6M | $357,449 |
| 2020 | 27 | 4,082 | 7,516 | $1.2M | $272,103 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,192 | 1,845 | $485,542 | $112,109 | 23.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 972 | 1,254 | $371,527 | $84,670 | 22.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 971 | 1,422 | $278,487 | $51,175 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 397 | 464 | $172,863 | $37,310 | 21.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 385 | 437 | $144,661 | $33,526 | 23.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 111 | 120 | $106,622 | $27,656 | 25.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 770 | 4,789 | $93,449 | $23,805 | 25.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 139 | 178 | $87,679 | $21,669 | 24.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 282 | 282 | $91,942 | $19,727 | 21.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 247 | 366 | $53,784 | $14,319 | 26.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 88 | 107 | $55,851 | $13,494 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $43,181 | $8,870 | 20.5% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 55 | 59 | $48,139 | $6,432 | 13.4% |
| 69100 | Biopsy of ear | Office | 2023 | 92 | 101 | $28,479 | $5,633 | 19.8% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 18 | 18 | $16,332 | $4,332 | 26.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 40 | 42 | $30,012 | $4,015 | 13.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 22 | 23 | $12,701 | $3,394 | 26.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 27 | $4,445 | $1,143 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,256 | 1,950 | $518,105 | $114,516 | 22.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 649 | 784 | $237,236 | $53,192 | 22.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 812 | 1,149 | $226,684 | $43,330 | 19.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 359 | 416 | $139,077 | $33,643 | 24.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 388 | 388 | $126,923 | $26,385 | 20.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 142 | 188 | $93,534 | $22,530 | 24.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 628 | 3,994 | $79,900 | $19,916 | 24.9% |
About Dr. Thomas Lambert, MD
Dr. Thomas Lambert, MD is a Dermatology healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1225252489.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Lambert, MD has received a total of $1,331 in payments from pharmaceutical and medical device companies, with $98.89 received in 2024. These payments were reported across 57 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,316).
As a Medicare-enrolled provider, Lambert has provided services to 19,413 Medicare beneficiaries, totaling 37,410 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Tyler, TX
- Active Since 04/12/2007
- Last Updated 01/17/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1225252489
Products in Payments
- DUPIXENT (Biological) $174.99
- Humira (Biological) $163.15
- ORACEA (Drug) $162.57
- ENSTILAR (Drug) $128.49
- ADBRY (Biological) $111.33
- BROMSITE (Drug) $102.92
- SKYRIZI (Biological) $71.11
- TREMFYA (Drug) $46.84
- HUMIRA (Biological) $40.60
- ABSORICA (Drug) $36.34
- DUPIXENT DUPILUMAB INJECTION (Biological) $32.31
- DUPIXENT (Drug) $24.71
- ILUMYA (Biological) $17.29
- EUCRISA (Drug) $16.61
- CLODERM (Drug) $16.60
- Avar (Drug) $15.19
- KERYDIN (Drug) $15.00
- BOTOX (Biological) $14.20
- EPIDUO FORTE (Drug) $12.98
- SOOLANTRA (Drug) $12.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Tyler
Jennifer Holman, Md, MD
Dermatology — Payments: $705,235
Lindsey Hunter-Ellul, Md, MD
Dermatology — Payments: $11,358
Martha Mccollough, Md, MD
Dermatology — Payments: $10,842
Leslie Markle, Md, MD
Dermatology — Payments: $8,660
Alma Berlingeri Ramos, Md, MD
Dermatology — Payments: $4,757
Jeffrey Harbold, Do, DO
Dermatology — Payments: $4,013